inhibitory glp 1 GLP-1 Drugs: For Multiple Chronic Conditions GLP-1 Therapies May Benefit MPN
Description
Lets look at the actual numbers from the SURPASS clinical trial program the largest trials ever done on a diabetes drug: To put this in perspective most diabetes drugs reduce HbA1c by 0.51%
Sublingual (under-the-tongue) GLP-1 agonists, such as semaglutide, represent a novel approach, promising similar benefits to injectable versions without the need for needles
VoraKAPorterGPengRCuiYPryorKEiermannGet al
Asami T, Nishizawa N, Nida A, et al
Learn more about GLP-1s and supplements here:
The introduction of the programs support strategies increased average relative weight loss, especially for those who did not initially respond to GLP-1 treatments
